98 related articles for article (PubMed ID: 33847190)
1. Randomized clinical trials and real life studies: Comparison of baseline characteristics of patients in oral target therapies for renal cell carcinoma.
Lasala R; Santoleri F; Romagnoli A; Musicco F; Abrate P; Costantini A
J Oncol Pharm Pract; 2022 Jun; 28(4):870-883. PubMed ID: 33847190
[TBL] [Abstract][Full Text] [Related]
2. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
3. Sunitinib for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World and Clinical Trials Data.
Moran M; Nickens D; Adcock K; Bennetts M; Desscan A; Charnley N; Fife K
Target Oncol; 2019 Aug; 14(4):405-416. PubMed ID: 31301015
[TBL] [Abstract][Full Text] [Related]
4. Reporting Quality of Randomized Controlled Trials of Periodontal Diseases in Journal Abstracts-A Cross-sectional Survey and Bibliometric Analysis.
Kumar S; Mohammad H; Vora H; Kar K
J Evid Based Dent Pract; 2018 Jun; 18(2):130-141.e22. PubMed ID: 29747793
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous vertebroplasty for treatment of painful osteoporotic vertebral compression fractures: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(19):1-45. PubMed ID: 23074396
[TBL] [Abstract][Full Text] [Related]
6. Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapy.
Castro DV; Prajapati SR; Feng MI; Chan EH; Lee KO; Paul T; Sehgal I; Patel J; Li X; Zengin ZB; Ebrahimi H; Govindarajan A; Meza L; Mercier BD; Chawla NS; Dizman N; Philip EJ; Hsu J; Bergerot CD; Chehrazi-Raffle A; Rock A; Liu S; Tripathi A; Dorff TB; Pal SK
BJU Int; 2024 Mar; 133(3):297-304. PubMed ID: 37548533
[TBL] [Abstract][Full Text] [Related]
7. Interventions for chronic kidney disease-associated restless legs syndrome.
Gopaluni S; Sherif M; Ahmadouk NA
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD010690. PubMed ID: 27819409
[TBL] [Abstract][Full Text] [Related]
8. The ineligible patient: how to treat patients not included in clinical studies.
Mao FJ; Rini BI
World J Urol; 2014 Feb; 32(1):9-18. PubMed ID: 23436165
[TBL] [Abstract][Full Text] [Related]
9. Airway clearance devices for cystic fibrosis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(26):1-50. PubMed ID: 23074531
[TBL] [Abstract][Full Text] [Related]
10. A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma.
Fernández-Pello S; Hofmann F; Tahbaz R; Marconi L; Lam TB; Albiges L; Bensalah K; Canfield SE; Dabestani S; Giles RH; Hora M; Kuczyk MA; Merseburger AS; Powles T; Staehler M; Volpe A; Ljungberg B; Bex A
Eur Urol; 2017 Mar; 71(3):426-436. PubMed ID: 27939075
[TBL] [Abstract][Full Text] [Related]
11. Impact of targeted therapies in metastatic renal cell carcinoma on patient-reported outcomes: Methodology of clinical trials and clinical benefit.
Dos Santos M; Brachet PE; Chevreau C; Joly F
Cancer Treat Rev; 2017 Feb; 53():53-60. PubMed ID: 28073101
[TBL] [Abstract][Full Text] [Related]
12. Incentives for preventing smoking in children and adolescents.
Hefler M; Liberato SC; Thomas DP
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD008645. PubMed ID: 28585288
[TBL] [Abstract][Full Text] [Related]
13. Augmenting the randomized controlled trial with real-world data to aid clinical decision making in metastatic renal cell carcinoma: a systematic review and meta-analysis.
Moran M; Nickens D; Adcock K; Bennetts M; Charnley N; Fife K
Future Oncol; 2019 Dec; 15(34):3987-4001. PubMed ID: 31623465
[No Abstract] [Full Text] [Related]
14. Demographics of patients receiving Intravitreal anti-VEGF treatment in real-world practice: healthcare research data versus randomized controlled trials.
Ziemssen F; Feltgen N; Holz FG; Guthoff R; Ringwald A; Bertelmann T; Wiedon A; Korb C;
BMC Ophthalmol; 2017 Jan; 17(1):7. PubMed ID: 28103831
[TBL] [Abstract][Full Text] [Related]
15. Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer.
Shepherd AR; Shepherd E; Brook NR
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012112. PubMed ID: 28268259
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
17. Expert Recommendations for First-Line Management of Metastatic Renal Cell Carcinoma in Special Subpopulations.
Puente J; García Del Muro X; Pinto Á; Láinez N; Esteban E; Arranz JÁ; Gallardo E; Méndez MJ; Maroto P; Grande E; Suárez C
Target Oncol; 2016 Apr; 11(2):129-41. PubMed ID: 26706236
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
